Table 2.
NFC (n = 55) | PFC (n = 12) | P value | |
---|---|---|---|
WHO PH classification* | |||
Group 1, PAH | 23 (42) | 1 (8) | 0.03 |
Group 2, PH-LHD | 27 (49) | 12 (100) | <0.001 |
Group 3, PH-Lung disease | 24 (44) | 4 (33) | 0.52 |
Group 4, CTEPH | 3 (5) | 2 (17) | 0.19 |
Group 5, Miscellaneous | 3 (5) | 1 (8) | 0.75 |
Initiation of PAH therapy | 28 (51) | 0 (0) | <0.001 |
Discharged from PH clinic | 15 (27) | 8 (67) | 0.02 |
Values are presented as n (%).
Some patients were classified as multifactorial PH with contributions from more than one WHO group
CTEPH, chronic thromboembolic PH; LHD, left heart disease; PAH, pulmonary arterial hypertension.